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Abstract 
The objective of this study was to optimize the analytical method for multi‑class veterinary drug residues of 64 com‑
pounds in fishery products. Several compounds from veterinary drugs are banned or unauthorized in fishery products 
according to the Korean Food Code. Samples were extracted using acetonitrile/water (4:1, v/v) and the clean‑up step 
was carried out by adding octadecylsilane and acetonitrile‑saturated hexane. The target compounds were confirmed 
and quantified using liquid chromatography–tandem mass spectrometry (LC–MS/MS). The proposed method was 
validated according to the CODEX guidelines (CAC/GL‑71), and most target compounds were found to be in accept‑
able quantities under the requirements of the validation guidelines. The recovery of analytes was typically in the 
60–120% range, and precision, expressed as the coefficient of variation was less than 31% at all levels of concentra‑
tion. The limit of quantification ranged from 0.03 to 3 μg  kg−1 in the fishery products. Moreover, the application of the 
proposed method to 96 real samples demonstrated that no drug residues exceeded the Korean maximum residue 
limits (MRLs). This evaluation method provides reliable identification and quantification of multi‑class veterinary drugs 
in fishery products and can be an efficient means to inspect drugs currently banned or not approved for aquaculture 
in Korea.
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Introduction
Global apparent food fish consumption has increased 
at an average annual rate of 3.1%, from 1961 to 2017, 
higher than the corresponding increase in other animal 
protein foods (meat, dairy, milk, etc.) that increased 
by an average of 2.1%. Fishes have become an import 
source of proteins and are supplied by capture fisher-
ies and aquaculture production. The latter accounts for 
46% of total production and 52% of human consump-
tion [1]. In order to achieve greater productivity, inten-
sive cultivation systems are employed, which increases 
susceptibility to diseases caused by parasitic, bacte-
rial, viral, and fungal infections [2]. Therefore, the use 
of veterinary drugs in aquaculture is necessary for the 
prevention and treatment of infectious diseases. How-
ever, even with careful use, residues of these drugs can 
remain in fishery products and affect public health [3]. 
In addition, there are instances of unapproved or prohib-
ited drugs used in aquaculture [4]. This practice carries 
potential risks related to the development of antibiotic 
resistance, which can lead to serious human health prob-
lems worldwide [5–7]. To restrict human exposure to 
veterinary drug residues, several governmental authori-
ties have established maximum residue limits (MRLs) 
to ensure the quality and safety of consumer products. 
In Korea, the Ministry of Food and Drug Safety (MFDS) 
regulates the use of veterinary drugs in food-producing 
animals, sets MRLs for approved veterinary drugs based 
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on acceptable daily intakes (ADIs) and develops standard 
analytical methods for veterinary drug residues in foods 
of animal origin. The MFDS, as a regulatory agency, also 
has the primary responsibility for ensuring food safety 
by inspecting imported and domestic fishery products. 
Our previous study showed that veterinary drugs were 
detected in fish samples in 217 of 958 samples (22.7%), 
and in 12 samples (1.3%) the drug content exceeded the 
Korean MRLs. Various compounds such as enrofloxa-
cin, oxytetracycline, and trimethoprim were detected in 
fishery products; enrofloxacin was the chemical most fre-
quently present in quantities exceeding the Korean MRLs 
[8]. In the Korean Food Code, analytical methods based 
on liquid chromatography–tandem mass spectrom-
etry (LC–MS/MS) have been used to detect multi-class 
residues in fish [9]. Although veterinary drugs for which 
MRLs have been established can be regulated, there is no 
way to control the distribution of food containing unap-
proved drugs in fishery products. In addition, the over-
use and improper application of veterinary drugs without 
observing the required withdrawal period can result in 
high residue levels in fish and, as a result, increase unin-
tentional human exposure leading to health risks [10]. 
In Korea, the percentage of imported fishery products 
is approximately 31% and has increased from 2011 to 
2018 [11]. Varying degrees of drug MRLs are imposed 
on fishery products imported from different countries, 
and these products are not inspected for drug residues 
outside these established MRLs or residue tolerances. In 
efforts to ensure food safety in Korea, the MFDS is pre-
paring to introduce a positive list system (PLS). The PLS 
program for veterinary drugs that will be implemented in 
2024 or after. Five major livestock (beef and derivatives, 
pork and derivatives, poultry and derivatives, milk and 
eggs) and fishery products will be subject to the PLS first. 
Thus far, in the absence of established MRLs in Korea, 
the current default policy has been to apply CODEX 
standards or, failing that, the lowest MRL set for similar 
products. However, with the implementation of the PLS, 
a default tolerance of 10 μg  kg−1 will apply to drugs with 
no established Korean MRLs. Following the full imple-
mentation of the new system, residual drug substances 
without established MRLs or residue tolerances will be 
subjected to law enforcement [12]. Accordingly, to ensure 
implementation of the PLS, the development of fast and 
reliable analytical methods that allow facile inspection of 
these unregulated veterinary drugs.
Several countries and institutions have adopted multi-
class simultaneous analysis to determine veterinary 
drug residues in animal products using LC–MS/MS. 
LC–MS/MS is the most significant quantitative analyti-
cal technique developed in recent years [13–16]. This 
method can be employed for developing a method for 
multiple analytes with a single sample preparation and 
the ability to determine target analytes in one run. The 
aim of this study was to develop a screening and con-
firmatory method suitable for analyzing a wide range of 
64 compounds in fish using LC–MS/MS with an opti-
mized extraction method. The selected analytes include 
drugs approved for use in food-producing animals 
other than fish (e.g., cefazoline) and drugs that are com-
pletely banned from use in all food-producing animals 
(e.g., clenbuterol). The method was validated in terms 
of its quantitative performance characteristics based on 
CODEX guidelines [17]. In addition, this method was 
applied to analyze commercial samples obtained from 
domestic markets to determine the residue levels of vari-
ous veterinary drugs. The evaluated method provides 
reliable identification and quantification of 64 com-




All high-purity (> 90%) chemical standards were pur-
chased from Sigma-Aldrich (St. Louis, MO, USA and 
Steinheim, Germany): acetanilide, azaperol, caffeine, 
carbendazim, chlorpromazine, clopidol, closantel, dimi-
nazene, diphenhydramine hydrochloride, loperamide, 
oxyclozanide, ractopamine, thiacloprid, tinidazole, toltra-
zuril sulfone, tripelennamine, and valnemulin. Arprino-
cid, halofuginone, isometamidium, monoacetyl dapsone, 
pirlimycin, yohimbine, and zilpaterol were purchased 
from Toronto Research Chemicals (Toronto, Canada). 
Antipyrine, berberine, cefazoline, cyproheptadine, and 
naloxone were purchased from USP (Rockville, MD, 
USA). The other compounds used were purchased from 
Dr. Ehrenstorfer (Augsburg, Germany). LC–MS grade 
acetonitrile (MeCN), methanol (MeOH), and n-hexane 
were purchased from Merck Inc. (Darmstadt, Ger-
many). Formic acid (≥ 95%) and dimethyl sulfoxide 
(DMSO) were purchased from Sigma-Aldrich (St. Louis, 
MO, USA). Octadecylsilane  (C18) (55–105  μm, 125  Å) 
was purchased from Waters (Milford, MA, USA) and a 
syringe filter from Teknokroma (Barcellona, Spain) was 
used in PTFE membrane filters (0.2 μm). Standard stock 
solutions (1000  μg/mL) of the investigated drugs were 
prepared in MeCN, MeOH, MeOH/water (50:50, v/v), 
water, and MeOH/DMSO (50:50, v/v), respectively. All 
stock solutions were stored in the dark at − 20 °C.
Sample collection and preparation
To evaluate the applicability of the proposed analytical 
method, we collected 10 kinds of fish species (n = 96): 
abalone (n = 11), catfish (n = 8), eel (n = 15), flat fish 
(n = 11), rockfish (n = 11) manila clam (n = 5), mudfish 
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(n = 10), salmon (n = 9), sea bream (n = 5) and shrimp 
(n = 11) from fish markets and websites. The specimens 
were randomly collected between April and September 
2020 in the Republic of Korea. The edible tissues (over 
500 g) of each sample were homogenized and stored in a 
freezer (− 20 °C) until further analysis.
Samples (2  g) were extracted with 10  mL of MeCN/
water (4:1, v/v) by shaking (5 min) and centrifugation at 
4500×g for 10  min. The supernatants were then trans-
ferred to a tube containing  C18 powder. Then, 10 mL of 
MeCN saturated in hexane was added, and the mixture 
was shaken for 1  min. The sample was centrifuged at 
4500×g for 5 min, and the bottom solution (5 mL) below 
the hexane layer was transferred to a new centrifuge tube. 
The sample was dried with nitrogen gas below 40  °C. 
The residue was dissolved in 1 mL of MeOH/water (1:1, 
v/v) and then filtered with a 0.2  μm PTFE filter before 
analysis.
LC–MS/MS method
For LC–MS/MS experiments, a Shimadzu LCMS 
8060 triple quadrupole mass spectrometer (Shimadzu, 
Kyoto, Japan) was used with a Waters X-SELECT HSS 
 C18 (2.1  mm × 150  mm, 3.5  μm particle size) chroma-
tographic column. The mobile phases were used water 
with aqueous 0.1% (v/v) formic acid (designated A), and 
MeCN with aqueous 0.1% (v/v) formic acid (designated 
B). The chromatographic separation was performed in 
gradient mode: 0–0.5 min, increase to 5% B, 0.5–5.5 min 
increase to 60% B, 5.5–6.0 min increase to 100% B, 6.0–
10.0 min maintained at 100% B, 10.0–10.2 min decrease 
to 5% B, and 10.2–12.0 min maintained at 5% B. A flow 
rate of 0.3  mL/min was used, and the injection volume 
was set at 5  μL. Mass analysis was performed using an 
electrospray ionization (ESI) source in both positive and 
negative switching modes. The capillary, column, and 
auto-sampler temperatures were set at 350, 40, and 15 °C, 
respectively. Additionally, the capillary voltage was both 
3.6 kV (positive) and − 2.8 kV (negative), the cone voltage 
was 30 kV in all compounds and argon gas was used.
Method validation
The proposed method was validated according to 
CODEX guidelines (CAC/GL-71). All concentration lev-
els used in the validation are listed in Table 2. The per-
formance parameters were selectivity, linearity, accuracy, 
precision, limit of detection (LOD), and limit of quan-
titation (LOQ). Linearity was demonstrated for all 64 
compounds by preparing a six-point matrix-matched cal-
ibration curve in the range of target concentrations (0.5–
80  μg   kg−1). Recovery and precision were determined 
by analyzing blank samples (flatfish, eel, and shrimp) at 
three different concentrations and estimated from five 
replicates for each concentration: 1, 2, and 10 μg  kg−1 for 
analytes with zero tolerance or 5, 10, and 20 μg  kg−1 for 
other analytes. Banned compounds and metabolites with 
zero tolerance were: dapsone, monoacetyl dapsone, dim-
etridazole, metronidazole, metronidazole-OH, ipronida-
zole, 2-methyl quinoxaline-2-carboxylic acid (MQCA), 
colchicine, and clenbuterol. Moreover, the following 
compounds were analyzed according to the marker resi-
due given in parentheses: olaquindox (MQCA), and tol-
trazuril (toltrazuril sulfone). Recoveries were calculated 
by comparing the concentrations of the extracted sam-
ples with those from the matrix-matched calibration 
curve. Matrix-matched standards for calibration checks 
were used regularly during the analysis. The LOD and 
LOQ were defined with a signal-to-noise (S/N) ratio of 
≥ 3 and ≥ 10, respectively. The LOQ were calculated ana-
lysing blank samples spiked at the lowest concentration 
of the analyte for which signal-to-noise ratio was 10. The 
peak to peak signal-to-noise ratios were used and they 
were calculated using LabSolutions software.
Results and discussion
LC–MS/MS analysis
This study was conducted to develop a quantitative 
analytical method for multi-class veterinary drugs that 
were not approved or banned in fishery products. The 
MS parameters were optimized by the direct infusion 
of individual veterinary drug solutions at 1000 μg   mL−1 
in MeOH/water (1:1, v/v) in the mass spectrometer. 
The electrospray source was used in positive or nega-
tive ionization mode to provide the highest signals. 
For each compound, the multiple reaction monitoring 
(MRM) transition with the highest intensity was used 
as the quantifier, while the other transition was used as 
the qualifier. The mass parameters for all analytes, such 
as collision energy and cone voltage, were optimized 
automatically by the software of the instrument. Table 1 
lists the specific MS/MS parameters and retention times 
of all target drugs in this study. For the majority of ana-
lytes, the [M+H]+ ion was sufficiently intensive that 
it could be selected as precursor ion for MS/MS. The 
rest of compounds appeared as negative hydride ions 
[M−H]− (closantel, clorsulon, diclazuril, efrotomycin, 
oxyclozanide, roxarsone, toltrazuril sufone). Others, 
like berberine, and isometamidium showed peaks cor-
responding to  [M]+; peaks for acriflavine corresponded 
to [M−Cl]+, while those for bacitracin corresponded to 
[M+3H]3+. Chromatographic analysis was based on a 
previously employed method for multi-class drug sepa-
ration [18]. The separation was performed in a reversed-
phase X-SELECT HSS  C18 (2.1  mm × 150  mm, 3.5  μm, 
Waters) column, and the mobile phases used were water 
with aqueous 0.1% (v/v) formic acid (designated A) and 
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Table 1 LC–MS/MS parameters of 64 compounds










Analgesics/antipyrectics Acetanilide + 135.1 135.9 43.0 31 4.92
51.0 50
77.0 30
Phenacetin + 179.1 179.9 65.1 37 5.54
93.0 28
110.0 22
Antidiarrheals Berberine + 336.1 336.0 263.0 53 5.32
278.0 43
304.0 33
Loperamide + 476.2 477.0 72.0 51 6.50
210.0 51
266.0 25
Antiemetics Metoclopramide + 299.1 299.8 140.9 49 4.27
184.0 31
226.9 20
Antifungals Fluconazole + 306.1 307.0 169.1 22 4.64
220.1 18
238.2 17
Antihistamine Cyproheptadine + 287.2 288.2 96.1 25 5.86
191.1 30
215.1 48
Diphenhydramine + 255.2 256.1 115.0 55 5.48
152.0 35
167.1 13
dl‑Methylephedrine HCl + 179.1 179.9 57.0 19 3.70
117.0 21
147.1 22
Tripelennamine + 255.2 256.1 72.1 32 4.83
91.0 36
119.0 34
Anti‑inflammatory Antipyrine + 188.1 188.9 56.0 34 4.58
58.5 34
104.0 25
Colchicine + 399.2 400.1 310.2 27 5.29
326.2 24
358.2 23
Ketoprofen + 254.1 255.1 77.1 45 6.99
105.0 22
209.1 15
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Table 1 (continued)










Benzimidazoles Carbendazim + 191.1 192.0 105.1 35 3.67
132.2 29
160.1 18
Clorsulon − 378.9 378.0 277.1 22 5.60
242.2 22
342.1 12
Closantel − 661.9 660.8 127.0 50 8.55
315.1 34
345.0 36
Diethylcarbamazine + 199.2 200.1 72.0 24 3.34
100.1 16
127.0 15
Emamectin benzoate + 885.5 886.2 82.1 55 7.38
126.2 43
158.0 35
Morantel + 220.1 221.2 111.1 25 4.64
123.0 25
164.0 25
Oxyclozanide − 400.9 399.9 202.1 22 7.60
363.9 17
381.9 22
Cefalosporines Cefazolin + 454.0 454.7 155.9 18 4.39
294.9 17
323.0 13
Cefoperazone + 645.1 645.8 143.0 36 4.78
148.0 52
530.0 12
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Table 1 (continued)










Coccidiostat Clopidol + 191.0 192.0 51.1 44 3.73
87.1 30
101.1 26
Diclazuril − 406.0 405.0 299.0 28 7.46
334.0 19
335.1 19
Diminazene + 281.1 282.0 102.1 37 3.05
119.1 17
254.2 9
Halofuginone + 413.0 414.0 100.1 24 4.90
120.1 21
138.1 20
Imidocarb + 348.2 349.0 145.1 55 3.26
162.2 25
188.1 29
Isometamidium + 460.2 460.2 269.1 50 4.45
298.1 25
313.1 20
Robenidine + 333.1 333.9 111.0 50 6.50
138.0 25
155.1 20
Roxarsone − 262.9 262.0 123.1 25 3.33
153.1 20
244.0 11
Toltrazuril − 457.1 456.0 42.2 22 7.31
399.1 12
Diaminopyrimidines Pyrmethamine + 248.1 249.1 177.0 30 4.95
198.1 45
233.1 28
Growth supplement Clenbuterol + 276.1 277.0 140.0 46 4.50
168.0 31
203.0 17
Nandrolone + 274.2 275.0 109.1 26 6.80
257.2 16
239.2 17
Ractopamine + 301.17 302.0 107.0 34 4.10
121.0 23
284.1 13
Zilpaterol + 261.15 262 185.1 25 3.10
202.1 19
244.2 14
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Table 1 (continued)










Lincosamides Pirlimycin + 410.2 411.1 56.1 52 4.62
112.1 30
363.1 19
Nitroimidazoles Dimetridazole + 141.1 142.1 81.1 26 3.88
95.1 23
96.1 15
Ipronidazole + 169.1 170.1 109.1 26 5.59
123.1 25
124.1 19
Metronidazole + 171.1 171.8 82.0 25 3.47
98.0 22
111.0 23
Metronidazole‑OH + 187.1 188.0 68.1 22 3.14
123.1 13
126.0 17
Tinidazole + 247.1 248.0 82.1 34 4.40
121.1 16
128.0 21
Pesticides Thiacloprid + 252.0 253.0 90.1 38 5.67
99.1 41
126.2 21
Polypeptides Baciitracin + 1421.7 475.2 86.1 22 4.74
110.1 49
199.1 28
Quinoxalines Olaquindox + 188.1 189.0 102.0 32 4.63
143.0 16
145.0 16
Sedative Arprinocid + 277.1 278.1 107.1 55 4.75
108.1 52
143.0 25
Azaperone + 327.2 328.2 95.1 64 4.35
121.1 19
123.1 44
Azaperol + 329.2 330.2 109.1 57 4.05
121.1 20
149.1 30
Carazolol + 298.2 299.2 116.1 21 4.91
194.1 30
222.1 20
Chlorpromazine + 318.1 319.1 58.1 30 6.18
86.1 20
246.0 24
Scopolamine + 303.1 303.8 103.0 38 3.85
138.0 22
156.0 17
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Table 1 (continued)










Sulfonamides Dapsone + 248.1 249.0 92.0 25 4.91
108.1 22
156.0 14
Monoacetyl dapsone + 290.1 291.0 92.0 30 5.06
108.1 23
156.1 17
Succinyl‑sulfathiazole + 355.0 356.0 108.1 27 4.18
192.1 24
256.1 17
Sulfabendzamide + 276.1 277.1 92.1 25 5.66
108.1 21
156.0 15
Sulfameter + 280.1 281.1 92.1 30 4.62
108.1 25
156.1 19
Sulfamoxol + 267.1 268.1 92.1 25 4.37
108.1 25
156.0 15
Sulfapyridine + 249.1 250.1 92.1 26 4.11
108.1 25
156.0 16
Sulfisomidine + 278.1 279.1 92.1 30 3.56
124.1 20
186.1 20
Others Caffeine + 194.1 195.1 42.1 33 3.88
110.1 23
138.1 20
Efrotomycin − 1144.6 1143.6 274.2 49 7.10
773.4 34
791.3 27
Naloxone + 327.1 328.0 212.0 40 3.53
253.1 27
268.0 27
Valnemulin + 564.4 565.0 147.0 39 6.11
164.0 32
263.1 19
Yohimbine + 354.2 355.1 117.0 52 4.69
144.0 31
a The bold text expressed as quantification ion
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Table 2 Validation results for the analytical method of 64 compounds in 3 kinds of food matrices
Compounds Spiking level (µg/
kg)
Flatfish (n = 5) Eel (n = 5) Shrimp (n = 5)
Rec. (%) CV (%) Rec. (%) CV (%) Rec. (%) CV (%)
Acetanilide 5 117.4 10.6 73.7 19.0 107.1 10.9
10 93.4 12.8 80.5 6.9 98.5 14.4
20 75.0 6.2 72.8 4.1 90.5 13.9
Antipyrine 5 88.0 11.6 67.4 24.8 100.5 13.0
10 79.0 2.2 76.7 4.1 100.6 8.6
20 71.3 6.2 74.5 9.1 95.0 11.4
Arprinocid 5 112.1 3.4 67.2 1.4 100.3 5.6
10 85.8 7.1 80.7 5.4 93.8 9.7
20 70.9 4.9 76.5 3.5 89.0 7.1
Azaperone 5 113.9 9.9 98.4 7.7 88.0 9.8
10 98.0 11.6 87.1 11.2 101.8 29.6
20 70.0 10.8 77.6 8.7 84.1 18.0
Azaperol 5 103.0 6.4 60.6 12.6 92.1 6.5
10 91.2 7.9 79.2 10.1 97.5 11.8
20 73.8 4.9 84.2 6.8 89.1 7.5
Bactitracin 5 93.4 13.3 82.6 24.6 115.8 11.4
10 65.3 29.3 74.7 3.5 89.8 12.7
20 78.4 8.8 81.3 10.6 78.9 6.8
Berberine 5 116.4 14.0 65.4 7.5 97.6 13.1
10 88.5 4.8 78.1 4.0 98.4 14.9
20 71.6 8.0 74.1 2.0 90.0 13.0
Caffeine 5 89.7 14.2 74.7 18.7 115.3 8.4
10 73.9 10.5 77.9 14.0 98.6 5.3
20 68.4 7.3 70.6 11.1 97.2 5.5
Carazolol 5 97.5 12.8 68.7 9.1 95.5 8.4
10 84.2 9.1 78.2 5.6 87.2 11.8
20 70.5 6.0 74.7 2.6 84.5 5.2
Carbendazim 5 120.4 3.9 104.4 6.4 108.8 9.4
10 88.9 5.9 88.9 2.2 93.2 8.2
20 68.1 9.1 65.4 9.9 83.3 7.3
Cefazolin 5 110.1 20.9 104.2 26.2 118.8 26.0
10 79.5 9.2 88.1 22.3 91.0 24.5
20 70.7 9.9 72.3 13.9 92.7 22.0
Cefoperazone 5 79.3 13.1 62.2 26.9 110.0 21.2
10 81.1 17.2 84.2 22.0 96.6 18.3
20 73.9 16.5 78.8 5.7 109.8 7.7
Chlorpromazine 1 118.0 11.4 119.5 6.1 81.6 24.4
2 86.0 9.4 80.5 17.1 114.5 14.9
10 63.1 9.6 78.2 22.3 87.6 23.0
Clenbuterol 1 69.1 26.2 72.6 28.9 112.9 25.9
2 88.6 22.6 80.7 9.1 90.6 19.5
10 75.2 9.5 78.7 6.0 83.8 9.2
Clopidol 5 98.4 11.7 60.4 26.9 95.3 16.1
10 110.1 20.9 74.3 22.2 98.5 11.0
20 79.5 9.7 71.5 5.6 99.5 11.4
Clorsulon 5 70.7 9.9 71.5 8.5 113.7 6.9
10 77.3 11.3 94.8 8.3 99.0 11.5
20 78.3 5.7 81.4 20.5 103.8 9.1
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Table 2 (continued)
Compounds Spiking level (µg/
kg)
Flatfish (n = 5) Eel (n = 5) Shrimp (n = 5)
Rec. (%) CV (%) Rec. (%) CV (%) Rec. (%) CV (%)
Closantel 5 98.4 12.7 75.1 19.5 105.4 10.3
10 92.1 4.7 90.9 5.9 101.9 9.6
20 82.8 18.2 92.9 12.6 98.9 14.0
Colchicine 1 61.5 30.8 99.7 13.6 98.0 5.5
2 70.5 12.0 81.8 4.7 95.8 15.2
10 68.1 7.2 77.5 6.0 92.6 9.8
Cyproheptadine 5 100.8 17.4 85.1 13.4 79.2 17.6
10 91.8 11.4 76.3 22.8 96.1 30.4
20 73.9 7.1 78.8 17.1 78.8 16.9
Dapsone 1 65.7 27.6 75.0 31.1 113.6 14.2
2 61.5 9.0 77.7 9.0 96.7 6.7
10 67.1 14.0 68.8 12.9 85.9 11.1
Monoacetyl dapsone 1 60.1 18.4 60.3 24.2 72.6 29.2
2 68.4 17.2 80.7 22.1 91.1 18.5
10 87.9 6.5 92.7 3.9 93.1 7.6
Diclazuril 5 98.1 12.1 67.7 6.4 119.8 2.7
10 90.5 3.8 94.0 10.5 119.3 4.4
20 91.8 9.9 96.0 4.4 116.0 2.5
Diethylcarbamazine 5 105.3 10.9 118.9 5.8 106.0 13.8
10 84.2 10.8 98.6 6.2 105.1 19.6
20 61.8 8.8 78.2 7.5 92.7 12.1
Dimetridazole 1 103.1 24.6 115.1 8.7 117.7 22.9
2 77.7 16.2 80.8 9.6 117.2 14.1
10 60.5 6.2 63.1 13.3 92.1 7.4
Diminazene 5 106.9 10.6 73.5 19.6 105.0 10.2
10 84.1 10.2 99.8 8.0 89.9 5.4
20 71.0 4.8 97.4 13.8 86.4 13.2
Diphenhydramine 5 96.2 8.0 80.1 13.4 81.2 23.7
10 92.3 14.2 73.5 19.5 117.8 2.7
20 72.7 8.1 61.9 9.2 99.1 29.2
dl‑Methylephedrine HCl 5 82.1 9.3 117.0 9.1 96.6 9.5
10 70.8 5.9 94.9 6.0 88.9 14.2
20 60.3 6.0 75.8 10.9 89.5 10.7
Efrotomycin 5 116.9 23.4 116.7 21.0 104.9 14.5
10 101.6 11.3 107.1 17.7 104.0 24.3
20 98.3 10.8 112.8 7.9 108.6 7.5
Emamectin benzoate 5 94.7 10.8 67.6 5.9 109.5 4.2
10 86.6 5.9 80.0 8.7 98.9 7.2
20 83.4 6.3 83.2 8.4 93.3 7.5
Fluconazole 5 113.9 8.3 72.5 7.5 108.6 6.9
10 89.0 5.0 79.0 4.2 99.9 9.2
20 70.2 5.1 73.4 4.5 95.9 8.6
Halofuginone 5 101.5 16.7 73.1 16.9 108.5 11.8
10 78.1 14.3 87.1 9.7 90.8 11.0
20 72.0 10.5 79.0 9.7 90.5 4.5
Imidocarb 5 83.9 19.9 115.3 11.4 104.5 19.0
10 85.1 7.8 111.6 27.0 104.5 17.2
20 80.1 5.9 118.1 7.3 90.4 30.5
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Table 2 (continued)
Compounds Spiking level (µg/
kg)
Flatfish (n = 5) Eel (n = 5) Shrimp (n = 5)
Rec. (%) CV (%) Rec. (%) CV (%) Rec. (%) CV (%)
Ipronidazole 1 107.1 18.3 75.0 22.1 85.0 10.0
2 95.2 10.3 64.0 4.7 107.3 22.7
10 62.6 6.0 62.0 5.9 88.1 13.0
Isometamidium 5 97.2 8.3 89.0 10.8 98.2 7.8
10 88.9 6.8 104.2 18.8 100.5 11.3
20 87.9 15.2 105.6 2.9 108.2 8.5
Ketoprofen 5 96.9 4.3 72.8 15.1 119.3 3.2
10 88.8 8.5 87.9 9.9 110.7 9.3
20 77.9 9.1 81.0 9.7 106.5 8.1
Loperamide 5 96.7 6.8 69.0 7.2 98.3 3.8
10 82.6 3.9 78.2 8.8 90.2 6.7
20 75.3 5.5 79.2 7.9 84.7 5.0
Metoclopramide 5 114.5 26.1 75.4 12.1 97.9 12.3
10 81.6 12.0 80.8 23.4 90.9 9.3
20 70.3 6.6 71.7 8.1 92.0 13.3
Metronidazole 1 89.3 12.3 107.2 7.8 120.3 13.2
2 70.9 18.3 66.9 9.0 105.1 8.9
10 60.9 7.7 63.3 15.3 90.0 8.8
Metronidazole‑OH 1 68.3 6.6 111.1 11.1 97.2 12.6
2 60.0 9.2 103.3 6.6 91.9 8.3
10 63.6 6.3 104.2 10.2 85.1 11.4
Morantel 5 95.8 6.3 73.9 6.2 108.4 5.7
10 85.5 9.7 83.9 3.6 107.6 16.0
20 71.5 5.2 79.1 4.6 102.9 8.6
Naloxone 5 102.4 11.1 68.6 23.2 101.3 6.6
10 80.6 4.9 79.6 7.0 100.8 8.7
20 70.9 4.2 79.7 7.4 89.1 10.4
Nandrolone 5 99.1 9.1 75.5 10.3 106.6 7.9
10 88.3 4.5 82.5 9.5 104.6 10.6
20 75.3 5.7 83.8 6.5 94.3 5.1
Olaquindox 1 92.5 6.2 72.1 12.1 75.7 10.7
2 86.5 6.9 82.6 10.4 89.2 7.3
10 70.5 7.5 64.7 5.1 62.7 14.0
Oxyclozanide 5 104.3 12.9 64.2 14.9 97.8 10.7
10 95.3 4.9 97.5 15.8 117.7 13.4
20 86.9 16.4 104.3 16.0 114.9 6.6
Phenacetin 5 117.9 9.6 110.6 9.5 101.4 13.9
10 88.8 8.1 95.8 6.1 99.3 13.2
20 72.0 9.7 74.6 8.3 93.1 8.8
Pirlimycin 5 115.2 5.5 70.8 10.2 105.3 6.5
10 82.9 6.4 79.7 3.9 94.9 5.7
20 72.9 5.2 74.7 3.8 90.7 5.5
Pyrmethamine 1 79.9 5.5 67.9 12.0 87.8 4.0
2 80.6 7.9 69.5 8.6 85.5 9.5
10 69.8 4.6 75.3 8.6 77.5 6.0
Ractopamine 5 87.8 7.6 60.5 12.3 94.4 2.9
10 81.9 5.6 79.6 3.4 91.8 7.5
20 72.6 6.6 75.0 4.1 88.6 6.5
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Table 2 (continued)
Compounds Spiking level (µg/
kg)
Flatfish (n = 5) Eel (n = 5) Shrimp (n = 5)
Rec. (%) CV (%) Rec. (%) CV (%) Rec. (%) CV (%)
Robenidine 5 98.0 13.9 67.9 17.8 80.1 12.5
10 71.7 12.7 74.7 4.8 77.3 16.1
20 82.3 20.3 70.2 15.1 72.2 17.8
Roxarsone 5 118.0 22.4 111.2 18.9 111.5 8.5
10 82.5 7.0 76.4 10.9 103.9 29.6
20 61.7 6.1 72.4 4.2 113.8 14.9
Scopolamine 5 97.1 6.9 61.6 11.6 111.8 11.7
10 82.1 4.9 74.1 11.5 97.1 11.6
20 70.5 10.5 79.4 7.8 89.0 6.9
Succinyl‑sulfathiazole 5 75.8 17.1 78.3 20.2 89.2 24.3
10 77.4 10.0 77.5 6.2 80.3 15.3
20 70.6 13.3 80.5 8.9 81.5 9.7
Sulfabendzamide 5 112.3 4.6 66.1 10.7 111.5 4.3
10 87.0 9.1 74.8 8.5 101.6 11.9
20 70.1 7.2 71.2 9.2 97.4 8.6
Sulfameter 5 105.5 11.8 62.6 11.2 111.5 4.3
10 81.8 11.5 72.7 8.7 101.6 11.9
20 70.4 14.2 69.8 9.3 97.4 8.6
Sulfamoxol 5 112.2 8.0 73.6 18.4 101.5 6.8
10 78.9 6.8 80.8 6.1 102.8 3.6
20 70.7 7.5 78.1 17.0 98.8 7.1
Sulfapyridine 5 115.3 7.9 113.5 4.6 110.9 7.1
10 91.7 9.5 94.1 9.1 100.3 7.4
20 71.4 4.6 74.1 6.7 93.8 7.7
Sulfisomidine 5 86.6 15.2 113.7 6.6 115.9 3.7
10 73.8 12.1 94.0 3.6 100.1 13.7
20 63.1 5.3 72.9 10.2 96.5 5.4
Thiacloprid 5 96.6 4.7 71.8 8.3 108.1 5.1
10 83.5 6.2 78.3 6.4 102.2 10.3
20 70.4 5.3 72.1 8.0 98.8 9.9
Tinidazole 5 117.0 8.6 72.2 23.0 104.6 7.1
10 92.2 8.8 83.0 8.5 98.3 7.0
20 70.8 9.9 73.0 3.0 92.2 10.5
Toltrazuril 5 78.8 11.2 79.1 17.5 99.2 14.6
10 91.4 5.6 107.6 3.1 111.8 11.6
20 90.3 7.5 114.3 4.9 118.9 7.2
Tripelennamine 5 110.5 20.9 81.9 21.1 110.0 11.9
10 115.7 9.6 69.9 12.8 115.9 21.4
20 83.0 14.0 73.6 14.3 97.2 18.0
Valnemulin 5 87.9 9.7 60.9 8.4 94.3 5.8
10 79.7 5.1 72.6 7.3 84.1 7.4
20 75.3 5.6 74.0 7.0 80.0 5.1
Yohimbine 5 111.9 8.3 71.4 19.9 88.8 4.3
10 81.3 6.9 78.8 4.8 87.7 11.7
20 70.2 8.7 77.3 9.9 89.2 8.9
Zilpaterol 5 96.1 6.8 73.8 9.2 113.5 6.5
10 80.4 8.2 83.2 7.9 105.6 10.3
20 70.0 7.0 75.2 5.9 98.9 10.3
Rec. recovery, CV coefficient validation
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MeCN with 0.1% (v/v) formic acid (designated B). Several 
different mobile phases consisting of water, methanol, 
and MeCN as the organic phase with different mobile 
additives, such as ammonium formate, were tested to 
achieve optimal conditions. It was determined that the 
combination of mobile phases consisting of water with 
aqueous 0.1% (v/v) formic acid and MeCN with aqueous 
0.1% (v/v) formic acid provided better peak shape and 
intensity for the majority of the target compounds. The 
optimal mobile gradient program was set to last 12 min 
to improve the selectivity and resolution of the target 
compounds.
Sample preparation methods
Various studies of multi-residue analytical methods 
have used a combination of water and organic solvents 
to extract target compounds from the matrix [19, 20]. In 
this study, sample extraction was optimized based on a 
previously employed method for multi-class drug analy-
sis of fishery products [18]. MeCN/water (4:1, v/v) was 
selected as the extraction solvent to afford high-extrac-
tion recovery and precipitate proteins in the sample. For 
better clean-up of the samples,  C18 absorbent was used 
to remove fats and non-polar interference compounds 
in the matrix [21], and MeCN-saturated in hexane was 
added to eliminate potential interference during analy-
sis and provide satisfactory recoveries for most com-
pounds [22].
Validation of the analytical method
Validation was achieved based on the criteria outlined in 
the CODEX guidelines (CAC/GL 71-2009). Six different 
concentration levels were applied (2.5, 5, 10, 20, 40, and 
80 μg   kg−1 for analytes with no specific limits; 0.5, 1, 2, 
10, 20, and 40 μg  kg−1; for analytes with zero tolerances), 
and matrix-matched calibration curves showed good 
linearity with a coefficient of determination  (r2) greater 
than 0.98. The chromatogram peaks of the representative 
compounds are presented in Additional file 1: Figure S1. 
The results of the recovery and precision experiments are 
listed in Table  2. The majority of analytes met CODEX 
requirements with recovery values typically in the range 
of 60–120% and a coefficient of variation (CV) less than 
31%, but relative few analytes were slightly outside the 
acceptable limits (carbendazim, diethylcarbamazine, 
dl-methylephedrine HCl, roxarsone, sulfasomidine in 
flatfish, carbendazim, diphenhydramine, and sulfameter 
in eel). Some losses occurred during sample prepara-
tion, although a slightly lower recovery with satisfactory 
repeatability (CV less than 10%) is not a significant prob-
lem. Although these results do not completely meet the 
requirements of the CODEX guideline for a quantitative 
confirmation method, such periodic outliers are expected 
in multi-class, multi-residue analyses [23]. A difference 
was observed in the results obtained for the three matri-
ces, which may be due to matrix effects. The LOQ ranged 
from 0.03 μg  kg−1 (pyrmethamine) to 3 μg   kg−1 (clorsu-
lon, toltrazuril sulfone and tripelennamine) in the three 
matrices (Table 3). The LOQs were in all cases less than 
3 μg   kg−1 and satisfied the criteria less than 10 μg   kg−1, 
which is a default LOQ for PLS. The LOQ values in this 
study are similar or lower than those from previous stud-
ies. Saxena et al. [22] reported that LOQs of 24 veterinary 
drugs were ranged from 5 to 10  μg   kg−1 in aquaculture 
shrimps and Dasenaki et al. [24] reported that LOQs of 
115 veterinary drugs were in all cases below 5 μg  kg−1 in 
fish tissue. 
This analytical method allows the simultaneous 
extraction of veterinary drugs with vastly different 
physicochemical properties from various matrices by 
employing a simple extraction solvent. Thus far, studies 
have been conducted on substances that have already 
been approved or frequently used in fish animals [18, 25]. 
Therefore, this study is particularly significant as it is the 
first report of the successful analysis of several drugs not 
currently approved in fish animals, approved for use in 
fish animals by other governments, and without any pub-
lished tolerances. However, further work is required to 
improve the established multi-class residue method and 
achieve better results for those compounds analyzed with 
insufficient accuracy.
Matrix effect
For complex samples such as fishery products, matrix 
effects (MEs) occur, especially when analyzing in ESI 
mode, wherein the signal is enhanced if the value is posi-
tive and suppressed if the value is negative. The matrix 
effect can be classified as (1) soft (− 20% < ME < 20%), 
(2) medium (− 50% < ME <  − 20% or 20% < ME < 50%), 
and (3) strong( ME <  − 50% or ME > 50%) [26]. Matrix-
matched and solvent standard curves were compared to 
evaluate the ME, which were calculated as follows:
The ME calculated for all compounds in each matrix 
are listed in Table  3. As shown in Table  3, a significant 
matrix effect is observed in this study. Most of the com-
pounds in fish tissue were subjected to signal suppres-
sion, whereas few compounds were subjected to signal 
enhancement. According to matrices, the matrix effects 
were mostly soft and medium in flat fish, but strong 
effects in eel and shrimp (strong effects were 12 com-
pounds in flat fish, 52 compounds in eel and 48 com-
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Table 3 Matrix effects and LOQ of 64 compounds
Compounds Flat fish Eel Shrimp
% matrix effect LOQs (µg/kg) % matrix effect LOQs (µg/kg) % matrix effect LOQs (µg/kg)
Acetanilide − 28 1 − 6 1 − 23 0.4
Antipyrine − 26 1 − 67 1 − 71 0.2
Arprinocid 20 0.4 − 93 0.4 − 93 0.1
Azaperone − 67 0.3 − 83 0.3 − 85 0.1
Azaperol − 62 2 − 94 1 − 94 1
Bacitracin − 48 1 − 57 1.3 − 51 0.3
Berberine − 4 0.5 − 89 0.5 − 88 0.2
Caffeine − 5 0.5 − 53 1 − 62 0.2
Carazolol − 7 0.4 − 88 0.5 − 88 0.2
Carbendazim − 1 0.4 − 84 0.5 − 94 0.1
Cefazolin 3 1 302 1 312 0.5
Cefoperazone 15 1 179 1 137 0.3
Chlorpromazine − 85 0.4 − 94 0.2 − 95 0.1
Clenbuterol − 20 0.3 115 0.4 138 0.1
Clopidol − 9 1 − 59 1 − 64 0.3
Clorsulon − 20 0.3 − 22 3 − 11 0.1
Closantel − 36 0.5 − 90 0.5 − 86 0.2
Colchicine 16 0.5 16 0.5 3 0.5
Cyproheptadine − 78 0.3 − 94 0.4 − 94 0.1
Dapsone 14 0.2 26 0.2 − 8 0.3
Monoacetyl dapsone − 2 0.5 46 0.2 − 19 0.3
Diclazuril − 21 0.2 − 94 0.3 − 92 0.3
Diethylcarbamazine − 62 1 − 82 2 − 90 2
Dimetridazole − 35 0.5 − 59 0.5 − 80 0.5
Diminazene − 75 0.4 − 62 1 − 46 0.4
Diphenhydramine − 55 0.3 − 75 0.04 − 84 0.2
dl‑Methylephedrine HCl − 55 0.3 − 58 1 − 78 0.1
Efrotomycin − 35 1 15 0.3 48 0.5
Emamectin benzoate − 27 0.2 − 88 0.4 − 84 0.1
Fluconazole 28 0.2 − 83 0.2 ‑82 0.1
Halofuginone − 23 0.1 − 54 1 − 53 0.1
Imidocarb 19 0.3 − 92 0.3 − 84 0.1
Ipronidazole − 73 0.5 − 72 0.5 − 57 0.5
Isometamidium 122 0.4 − 82 0.4 − 61 0.1
Ketoprofen − 12 1 − 89 0.5 − 89 0.2
Loperamide − 31 0.2 − 97 0.3 − 96 0.1
Metoclopramide − 27 1 − 32 1 − 29 0.4
Metronidazole 27 0.5 132 0.5 − 37 0.5
Metronidazole‑OH 48 0.5 423 0.5 − 37 0.5
Morantel 35 1 − 87 1 − 88 0.4
Naloxone − 35 0.4 − 68 0.5 − 62 1
Nandrolone − 16 2 − 34 0.4 − 4 0.3
Olaquindox 40 0.3 41 0.2 − 27 0.1
Oxyclozanide − 26 0.3 − 94 0.2 − 93 0.1
Phenacetin − 12 1 − 49 1 − 64 0.3
Pirlimycin − 6 0.3 − 93 0.3 − 93 0.1
Pyrmethamine − 27 0.1 − 78 0.2 2 0.03
Ractopamine − 23 0.2 − 91 0.4 − 90 0.3
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ME% was very varying it means that significant MEs were 
observed for most analytes and it is consistent with other 
studies [23, 24]. The best way to overcome the matrix 
effect is the use of internal standards [24]. However, some 
internal standards are expensive, and finding appropriate 
internal standards for each analyte is difficult and unfea-
sible. Therefore, the matrix effect was compensated for 
by carrying out a matrix-matched calibration or through 
the standard addition method. These methods can be 
used for the correct quantification of target compounds 
in the analysis of real samples.
Application to real samples
In this study, we analyzed the levels of veterinary drug 
residues in domestic fishery products. We collected a 
total of 96 fishery samples from diverse provinces in 
Korea. Analysis of the samples showed that sulfisomi-
dine was detected in salmon at 2 μg  kg−1 and sulfame-
ter was detected in catfish at 40 μg  kg−1. Sulfonamides, 
including sulfisomidine and sulfameter are widely used 
in veterinary medicine and aquaculture for the preven-
tion and treatment of microbial infections. Because of 
the low cost and high effectiveness of sulfonamides, 
they are the most frequently used antibiotics [27]. In 
previous studies, sulfamethoxazole was found at rela-
tively low concentrations of 0.54–68.0  μg   kg−1 in fish 
muscles, while high concentrations of sulfadiazine at 
6.5–143.3  μg   kg−1 were reported in mollusks [28, 29]. 
Caffeine was detected in abalone, catfish, and mudfish 
at 1, 2, and 5 μg   kg−1, respectively. Caffeine is consid-
ered one of the most widely used pharmacologically 
active compounds (PhACs) pollutant because of its 
high abundance in the environment [30]. Pharmaceuti-
cals are usually highly water-soluble, and when released 
into marine environments, fish and other aquatic 
organisms accumulate these PhACs [31]. In addition, 
previous studies have demonstrated the potent antimi-
crobial pharmacological properties of caffeine against 
bacterial fish pathogens in  vitro [32]. However, there 
is no MRL imposed on caffeine in animal products in 
various countries. Therefore, few studies have reported 
caffeine residues in animal and fishery products. In 
other studies, caffeine was found at concentrations 
of 1.07, 1.00, and 1.37  μg   kg−1 in black rockfish, gray 
mullet, and red sea beam, respectively [33]. Our study 
detected 3 veterinary drugs (sulfisomidine, sulfameter, 
and caffeine) from the 5 fishery samples (Table 4); how-
ever, the Korean MRLs were not exceeded in any of the 
tested samples. According to the monitoring results, 
this proposed method can be applied to determine the 
concentration of veterinary drug residues in fishery 
products. When the PLS system comes into effect, we 
expect that the established method will show successful 
analytical performance in fish inspection programs.
Table 3 (continued)
Compounds Flat fish Eel Shrimp
% matrix effect LOQs (µg/kg) % matrix effect LOQs (µg/kg) % matrix effect LOQs (µg/kg)
Robenidine − 91 2 − 89 1 − 87 2
Roxarsone − 33 2 106 2 − 32 2
Scopolamine − 20 0.2 − 70 0.4 − 67 0.1
Succinyl‑sulfathiazole 17 1 − 65 1 − 64 0.3
Sulfabendzamide 23 1 − 60 0.3 − 69 0.3
Sulfameter 14 0.8 18 0.3 − 5 0.3
Sulfamoxol 58 1 − 73 1 − 58 0.3
Sulfapyridine 7 0.4 − 71 0.3 − 81 0.1
Sulfisomidine − 19 0.4 − 84 0.5 − 87 0.1
Thiacloprid 23 0.4 − 89 0.5 − 90 0.1
Tinidazole 13 0.4 − 51 0.4 − 65 0.1
Toltrazuril − 26 2 − 48 3 − 42 1
Tripelennamine − 44 3 153 2 87 1
Valnemulin − 27 0.3 − 76 0.3 − 75 0.1
Yohimbine 8 0.5 − 53 0.3 − 53 0.2
Zilpaterol 3 0.4 − 83 0.3 − 86 0.2
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